XML 21 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Sep. 27, 2020
Sep. 29, 2019
Sep. 30, 2018
Cash flows from operating activities:      
Net income $ 173,890,000 $ 158,761,000 $ 136,957,000
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 24,611,000 28,844,000 38,636,000
Equity in income of unconsolidated joint ventures (6,605,000) (4,073,000) (4,008,000)
Distributions of earnings from unconsolidated joint ventures 6,310,000 4,048,000 3,440,000
Amortization of stock-based awards 19,424,000 17,618,000 19,582,000
Deferred income taxes 565,000 (37,615,000) (29,360,000)
Provision for doubtful accounts 1,267,000 16,964,000 7,167,000
Impairment of goodwill 15,800,000 7,755,000 0
Fair value adjustments to contingent consideration (14,971,000) 1,085,000 4,252,000
(Gain) loss on sale of assets and divested business (11,066,000) (232,000) 1,045,000
Changes in operating assets and liabilities, net of effects of business acquisitions:      
Accounts receivable and contract assets 154,748,000 (10,226,000) (46,273,000)
Prepaid expenses and other assets (11,321,000) 2,568,000 (12,638,000)
Accounts payable (102,162,000) 39,011,000 (16,032,000)
Accrued compensation (8,173,000) 18,359,000 27,492,000
Contract liabilities 5,894,000 (6,039,000) 15,228,000
Other liabilities 19,460,000 (16,929,000) 24,998,000
Income taxes receivable/payable (5,192,000) (11,386,000) 17,596,000
Cash settled contingent earn-out liability 0 0 (2,349,000)
Net cash provided by operating activities 262,479,000 208,513,000 185,733,000
Cash flows from investing activities:      
Payments for business acquisitions, net of cash acquired (68,488,000) (84,159,000) (68,256,000)
Capital expenditures (12,245,000) (16,198,000) (9,726,000)
Proceeds from sale of assets and divested business, net 17,710,000 651,000 35,348,000
Net cash used in investing activities (63,023,000) (99,706,000) (42,634,000)
Cash flows from financing activities:      
Proceeds from borrowings 344,991,000 417,262,000 401,965,000
Repayments on long-term debt (331,066,000) (415,491,000) (485,946,000)
Repurchases of common stock (117,188,000) (100,000,000) (75,000,000)
Taxes paid on vested restricted stock (11,166,000) (6,893,000) (8,871,000)
Payments of contingent earn-out liabilities (22,900,000) (12,018,000) (1,412,000)
Debt pre-payment costs 0 0 (1,737,000)
Stock options exercised 10,334,000 11,751,000 13,520,000
Dividends paid (34,743,000) (29,674,000) (24,477,000)
Principal payments on finance leases (1,311,000) 0 0
Net cash used in financing activities (163,049,000) (135,063,000) (181,958,000)
Effect of exchange rate changes on cash, cash equivalents and restricted cash 207,000 (1,727,000) (4,947,000)
Net increase (decrease) in cash, cash equivalents and restricted cash 36,614,000 (27,983,000) (43,806,000)
Cash, cash equivalents and restricted cash at beginning of year 120,901,000 148,884,000 192,690,000
Cash, cash equivalents and restricted cash at end of year 157,515,000 120,901,000 148,884,000
Cash paid during the year for:      
Interest 13,256,000 12,310,000 15,570,000
Income taxes, net of refunds received of $1.4 million, $5.2 million and $2.5 million 55,039,000 66,038,000 49,842,000
Reconciliation of cash, cash equivalents and restricted cash:      
Total cash, cash equivalents and restricted cash $ 157,515,000 $ 148,884,000 $ 148,884,000